Fig. 1.
Fig. 1. Incidence of EBV reactivation. / Incidence of EBV reactivation after TCD-allogeneic SCT with ATG (n = 24), TCD-SCT without ATG (n = 61), and non–TCD-SCT (n = 65). Only TCD combined with ATG significantly increased the risk of EBV reactivation (P < .001).

Incidence of EBV reactivation.

Incidence of EBV reactivation after TCD-allogeneic SCT with ATG (n = 24), TCD-SCT without ATG (n = 61), and non–TCD-SCT (n = 65). Only TCD combined with ATG significantly increased the risk of EBV reactivation (P < .001).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal